Synapse - Works

Results (936)

Long-term clinical activity, safety and patient-reported quality of life for emactuzumab-treated patients with diffuse-type tenosynovial giant-cell tumour

Journal Article

Cassier, P. A.; Italiano, A.; Gomez-Roca, C.; Le Tourneau, C.; Toulmonde, M.; D'Angelo, S. P.; Weber, K.; Loirat, D.; Jacob, W.; Jegg, A. M.; more...
European Journal of Cancer (2020)

Fulltext@MSK | Save

Long-term efficacy, tolerability, and overall survival in patients with unresectable or metastatic platelet-derived growth factor receptor A (PDGFRA) D842V-mutant gastrointestinal stromal tumors (GIST) treated with avapritinib: NAVIGATOR phase 1 trial update

Meeting Abstract

Bauer, S.; Serrano, C.; von Mehren, M.; George, S.; Heinrich, M. C.; Kang, Y. K.; Schöffski, P.; Cassier, P. A.; Mir, O.; Eskens, F.; more...
Oncology Research and Treatment (2020)

Fulltext@MSK | Save

KRT-232, a first-in-class, murine double minute 2 inhibitor (MDM2i), for TP53 wild-type (p53(WT)) Merkel cell carcinoma (MCC) after anti-PD-1/L1 immunotherapy

Meeting Abstract

Wong, M. K. K.; Kelly, C. M.; Burgess, M. A.; Lewis, K.; Grewal, J. S.; Olszanski, A. J.; McGreivy, J.; Rothbaum, W.; Qamoos, H.; DeCaprio, J. A.
Journal of Clinical Oncology (2020)

Fulltext@MSK | Save

Long-term follow-up for duration of response (DoR) after weekly nab-sirolimus in patients with advanced malignant perivascular epithelioid cell tumors (PEComa): Results from a registrational open-label phase II trial, AMPECT

Meeting Abstract

Wagner, A. J.; Ravi, V.; Riedel, R. F.; Ganjoo, K. N.; Van Tine, B. A.; Chugh, R.; Cranmer, L. D.; Gordon, E. M.; Hornick, J. L.; Kwiatkowski, D. J.; more...
Journal of Clinical Oncology (2020)

Fulltext@MSK | Save

Association of immune-related adverse events (irAEs) with improved clinical outcome in sarcoma patients treated with immune checkpoint blockade (ICB)

Meeting Abstract

Rosenbaum, E.; Seier, K.; Kelly, C. M.; Kiesler, H.; Martindale, M.; Nicholls, C.; Chi, P.; Dickson, M. A.; Gounder, M. M.; Keohan, M. L.; more...
Journal of Clinical Oncology (2020)

Fulltext@MSK | Save

A randomized phase II study of MLN0128 (M) versus pazopanib (P) in patients (pt) with advanced sarcoma (Alliance A091304)

Meeting Abstract

Ingham, M.; Mahoney, M. R.; Remotti, F.; Shergill, A.; Dickson, M. A.; Riedel, R. F.; Attia, S.; Elias, A. D.; Liebner, D. A.; Agulnik, M.; more...
Journal of Clinical Oncology (2020)

Fulltext@MSK | Save

Quality of life (QoL) and self-reported function with ripretinib in ≥4th-line therapy for patients with gastrointestinal stromal tumors (GIST): Analyses from INVICTUS

Meeting Abstract

Heinrich, M. C.; George, S.; Zalcberg, J. R.; Bauer, S.; Gelderblom, H.; Schoffski, P.; Serrano, C.; Jones, R. L.; Attia, S.; D'Amato, G. Z.; more...
Journal of Clinical Oncology (2020)

Fulltext@MSK | Save

Phase II trial of bicalutamide in combination with palbociclib for the treatment of androgen receptor (+) metastatic breast cancer

Meeting Abstract

Gucalp, A.; Boyle, L. A.; Alano, T.; Arumov, A.; Gounder, M. M.; Patil, S.; Feigin, K.; Edelweiss, M.; D'Andrea, G.; Bromberg, J.; more...
Journal of Clinical Oncology (2020)

Fulltext@MSK | Save

Efficacy, safety, and immune priming effect of tazemetostat in patients with epithelioid sarcoma

Meeting Abstract

Gounder, M. M.; Stacchiotti, S.; Schoffski, P.; Cote, G. M.; Villalobos, V. M.; Jahan, T. M.; Chen, T. W. W.; Ratan, R.; Gupta, A. A.; Dileo, P.; more...
Journal of Clinical Oncology (2020)

Fulltext@MSK | Save

Safety profile of ripretinib, including impact of alopecia, and Palmar-Plantar Erythrodysesthesia Syndrome (PPES) on patient-reported outcomes (PROs), in ≥ fourth-line advanced gastrointestinal stromal tumors (GIST): Analyses from INVICTUS

Meeting Abstract

George, S.; Heinrich, M. C.; Zalcberg, J. R.; Bauer, S.; Gelderblom, H.; Schoffski, P.; Serrano, C.; Jones, R. L.; Attia, S.; D'Amato, G. Z.; more...
Journal of Clinical Oncology (2020)

Fulltext@MSK | Save